Author:
Ahmed K.A.,Abuodeh Y.A.,Echevarria M.I.,Arrington J.A.,Stallworth D.G.,Hogue C.,Naghavi A.O.,Kim S.,Kim Y.,Patel B.G.,Sarangkasiri S.,Johnstone P.A.S.,Sahebjam S.,Khushalani N.I.,Forsyth P.A.,Harrison L.B.,Yu M.,Etame A.B.,Caudell J.J.
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Which is the best treatment for melanoma brain metastases? A Bayesian network meta-analysis and systematic review;Critical Reviews in Oncology/Hematology;2024-02
2. A single‐center retrospective analysis of prognoses in patients with melanoma brain metastases and effectiveness of treatment in Japan;Cancer Medicine;2023-12
3. Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study;The Lancet Oncology;2023-12
4. Stereotactic radiosurgery and anti-PD-1 + CTLA-4 therapy, anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitors, or conventional chemotherapy for the management of melanoma brain metastases;European Journal of Cancer;2023-10
5. Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases;Holistic Integrative Oncology;2023-08-25